četvrtak, 10.09.2009.
Patients#39; Weight Drops, Vivus#39;s Stock Rises on Obesity Drug Trial ...
Patients#39; Weight Drops, Vivus#39;s Stock Rises on Obesity Drug Trial ...
More fuel for the on-going fire of dispute over efforts to link increasing obesity to high fructose corn syrup. Yale Professor Gerald Shulman, writing in Cell.
What#s the deal with this never-ending discussion of obesity among McArdle, Ambinder, David Frum, and some of Sully#s readers? I don#t have the energy to sort through it, so could somebody describe it in 30 words or less? ...
Drugmaker Vivus Inc. said Wednesday its obesity drug candidate Qnexa met key weight loss goals in two late-stage studies.
Here#s another frightening reason to slim down: Obesity ages the brain by 16 years! LA Times. This fitness challenge is only for the super hard-core -- running up 75 stories to reach the top of the US Bank Tower! Are you up for it? ...
Mountain View-based drug maker Vivus Inc. announced their obesity drug Qnexa met significant weight loss goals in two late-stage studies. Qnexa is a proprietary.
Bacardi Mojito Youtube Background
naughty girl
naturism free gallery
northwest
m16 nko answers
naruto manga
Today#39;s Time Waster: NBA 2K10 Draft Combine
michaels craft store website
chest pain nexium
microsoft virtual machine downloads
